Омикс
Producer: Universal agency "Pro-Pharma" Ukraine
Code of automatic telephone exchange: G04CA02
Release form: Firm dosage forms. Capsules.
General characteristics. Structure:
Active ingredient: tamsulozina hydrochloride;
1 capsule contains a tamsulozin a hydra of chloride of 0,4 mg;
Excipients: cellulose microcrystallic, коликоат MAY 30 DP, gipromeloz (gidroksipropilmetiltsellyuloz), propylene glycol, talc, magnesium stearate, sodium lauryl sulfate.
Pharmacological properties:
Pharmacodynamics. Selectively and competitively blocks postsynaptic a 1A - the adrenoceptors which are in smooth muscles of a prostate, a neck of a bladder and a prostatic part of an urethra. Reduces a tone of smooth muscles of a prostate, neck of a bladder and a prostatic part of an urethra, improving release of urine. At the same time the symptoms of obstruction and irritation connected with a high-quality prostatauxe decrease. The therapeutic effect develops in 2 weeks after an initiation of treatment. Tropism to a 1A - the adrenoceptors located in a bladder by 20 times exceeds its ability to interact with a 1B - the adrenoceptors which are in unstriated muscles of vessels. Behind high selectivity does not cause clinically significant decrease in system arterial pressure both in patients with hypertensia, and in patients with normal arterial pressure.
Pharmacokinetics. After intake it is quickly and almost completely soaked up in digestive tract. Bioavailability makes about 100%. After a single dose in 400 mkg the maximum concentration of active agent in plasma is reached in the 6th hour.
In a condition of equilibrium concentration (in 5 days of course use) values of the maximum concentration of active agent in a blood plasma are 60-70% higher, than after a single dose of drug. Linkng with proteins of plasma - 99%. Tamsulozin is not subject effect of "the first passing" through a liver and biotransformirutsya slowly in a liver with formation pharmacological of the active metabolites keeping high selectivity to a 1A - adrenoceptors. The most part of active agent is in blood in not changed look. It is removed by kidneys, 9% of a dose are removed in not changed look.
Elimination half-life of a tamsulozin at a single dose - 10 h, final time of semi-removal - the 22nd hour.
Indications to use:
Symptomatic treatment of a benign hyperplasia of a prostate.
Route of administration and doses:
Inside, without chewing, after a breakfast, washing down with enough water, on 1 capsule (0,4 mg). The term of treatment is determined by the doctor.
Features of use:
With care apply at predisposition to orthostatic hypotension, the expressed abnormal liver functions and KK (Cl) it is lower than 10 ml/min. At emergence of symptoms of orthostatic hypotension (dizziness, weakness) of the patient it is recommended to seat or lay.
Before an initiation of treatment it is necessary to verify the diagnosis.
It is necessary to be careful when working, connected with high concentration of attention and at control of vehicles (in connection with possible developing of dizziness).
Side effects:
From cardiovascular system: seldom - dizziness, orthostatic hypotension, a heart consciousness.
From TsNS: sometimes - a headache, an adynamy.
From a reproductive system: seldom - a retrograde eyakolyation.
From digestive tract: seldom - nausea, vomiting, diarrhea, a lock.
Allergic reactions: sometimes - skin rash, an itch, a Quincke's disease.
In case of any unusual reactions surely consult to the doctor of rather further use of drug!
Interaction with other medicines:
At simultaneous use with Cimetidinum perhaps some increase in concentration of a tamsulozin in a blood plasma, and with furosemide - decrease in concentration, however it does not demand changes of a dosage of drug. Diclofenac and indirect anticoagulants (warfarin) can increase the speed of elimination of a tamsulozin several. Co-administration with other a 1A - adrenoceptors can lead to the expressed strengthening of hypotensive effect.
Contraindications:
The increased individual sensitivity, orthostatic hypotension in the anamnesis, a heavy liver and/or renal failure. Children's age.
Overdose:
Symptoms: Developing of acute hypotension is possible.
Treatment: to give to the patient horizontal position with the raised legs. If symptoms do not disappear, it is necessary to administer obyemozamishchuyuch solutions or the vasoconstrictive drugs. For prevention of further absorption of drug the gastric lavage, reception activated is possible
Storage conditions:
In the dry, protected from light place, at a temperature of 15-25 °C.
Issue conditions:
According to the recipe
Packaging:
On 10 capsules in a blister strip packaging. 1 or 3 blister strip packagings in a pack from a cardboard.